Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation for Long-term Use.

Trial Profile

Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation for Long-term Use.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 May 2013

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Acronyms ENSURE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Feb 2013 Planned end date changed from 1 Jun 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
    • 17 Jan 2012 Actual patient number (1500) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top